Constantine Davides
Stock Analyst at Citizens JMP
(0.10)
# 4,661
Out of 4,974 analysts
176
Total ratings
36.4%
Success rate
-12.4%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Reiterated: Buy | $31 → $33 | $27.76 | +18.88% | 9 | Sep 8, 2026 | |
| NRC NRC Health | Reiterated: Buy | $23 → $26 | $21.96 | +18.40% | 2 | Jul 29, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $21 → $27 | $19.67 | +37.26% | 3 | Jul 20, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $122 → $111 | $96.51 | +15.01% | 9 | Jun 1, 2026 | |
| USPH U.S. Physical Therapy | Reiterated: Buy | $113 → $98 | $81.75 | +19.88% | 6 | May 8, 2026 | |
| ADUS Addus HomeCare | Reiterated: Buy | $150 → $142 | $115.88 | +22.54% | 8 | May 6, 2026 | |
| OPCH Option Care Health | Reiterated: Buy | $38 → $32 | $23.52 | +36.05% | 17 | Apr 30, 2026 | |
| AMN AMN Healthcare Services | Reiterated: Buy | $22 → $24 | $34.15 | -29.72% | 18 | Feb 23, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $48 → $34 | $26.67 | +27.48% | 3 | Feb 18, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $11 → $10 | $3.74 | +167.38% | 14 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $24 | $7.56 | +217.46% | 14 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $31 | $20.36 | +52.26% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $18.41 | n/a | 6 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.40 | n/a | 7 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $92.12 | n/a | 9 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $29.65 | n/a | 6 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.56 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $6.86 | n/a | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $0.3315 | n/a | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $26.29 | n/a | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $20.84 | n/a | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.25 | $1.05 | n/a | 2 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.0001 | n/a | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.5 | $2.05 | n/a | 1 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.2893 | n/a | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $2.23 | n/a | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $33 | $0.7371 | n/a | 3 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $68 | $0.54 | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $8 | $1.75 | n/a | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.25 | $1.33 | n/a | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.3 | $0.50 | n/a | 1 | Aug 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.7101 | n/a | 1 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $58.18 | n/a | 1 | Sep 27, 2011 |
Progyny
Sep 8, 2026
Reiterated: Buy
Price Target: $31 → $33
Current: $27.76
Upside: +18.88%
NRC Health
Jul 29, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $21.96
Upside: +18.40%
Omada Health
Jul 20, 2026
Reiterated: Buy
Price Target: $21 → $27
Current: $19.67
Upside: +37.26%
HealthEquity
Jun 1, 2026
Reiterated: Buy
Price Target: $122 → $111
Current: $96.51
Upside: +15.01%
U.S. Physical Therapy
May 8, 2026
Reiterated: Buy
Price Target: $113 → $98
Current: $81.75
Upside: +19.88%
Addus HomeCare
May 6, 2026
Reiterated: Buy
Price Target: $150 → $142
Current: $115.88
Upside: +22.54%
Option Care Health
Apr 30, 2026
Reiterated: Buy
Price Target: $38 → $32
Current: $23.52
Upside: +36.05%
AMN Healthcare Services
Feb 23, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $34.15
Upside: -29.72%
Waystar Holding
Feb 18, 2026
Reiterated: Buy
Price Target: $48 → $34
Current: $26.67
Upside: +27.48%
Evolent Health
Jan 6, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $3.74
Upside: +167.38%
Nov 7, 2025
Reiterated: Buy
Price Target: $23 → $24
Current: $7.56
Upside: +217.46%
Nov 7, 2025
Reiterated: Buy
Price Target: $30 → $31
Current: $20.36
Upside: +52.26%
Jul 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $18.41
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.40
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $92.12
Upside: n/a
Feb 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $29.65
Upside: n/a
May 25, 2023
Initiated Coverage: Buy
Price Target: $18
Current: $1.56
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $125
Current: $6.86
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $19
Current: $0.3315
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $15
Current: $26.29
Upside: n/a
May 10, 2023
Reiterated: Buy
Price Target: $23
Current: $20.84
Upside: n/a
Apr 18, 2023
Reiterated: Buy
Price Target: $5.25
Current: $1.05
Upside: n/a
Mar 30, 2023
Reiterated: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 20, 2023
Initiated Coverage: Buy
Price Target: $8.5
Current: $2.05
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $6
Current: $0.2893
Upside: n/a
Feb 15, 2023
Reiterated: Buy
Price Target: $15
Current: $2.23
Upside: n/a
Dec 30, 2022
Reiterated: Buy
Price Target: $50 → $33
Current: $0.7371
Upside: n/a
Oct 18, 2022
Initiated Coverage: Buy
Price Target: $68
Current: $0.54
Upside: n/a
Sep 28, 2022
Reiterated: Buy
Price Target: $14 → $8
Current: $1.75
Upside: n/a
Sep 23, 2022
Reiterated: Buy
Price Target: $4.25
Current: $1.33
Upside: n/a
Aug 18, 2022
Reiterated: Buy
Price Target: $2.3
Current: $0.50
Upside: n/a
Mar 14, 2022
Initiated Coverage: Buy
Price Target: $4
Current: $0.7101
Upside: n/a
Sep 27, 2011
Initiated Coverage: Buy
Price Target: $41
Current: $58.18
Upside: n/a